声明 | 欧盟中国商会反对欧委会IPI下排斥中企参与医疗器械环球采购

　　开端：CCCEU 

　　欧盟中国商会反对欧委会在IPI下排斥中企参与欧盟医疗器械环球采购

　　2025年6月20日，比利时布鲁塞尔

　　6月20日，欧委会秘书在《国外采购器用》（IPI）首个造访后，排斥中企在欧盟参与研究环球采购，并条款中标名目中来自中国的居品及零部件比例不得提高50%。欧盟中国商会对欧方这一单边保护目标作念法、欧方公开对中企接收不公谈的脑怒性步调暗示执意反对。

　　商会以为，欧方IPI造访效果并不公允，其“大部分中方医疗环球采购市集排斥或脑怒欧盟制造的医疗器械及欧盟供应商”论断不适合履行。此外，中国与欧盟在内的买卖伙伴历久就GPA及环球采购问题保抓估计，双向相似渠谈遥远畅通。在此布景下，欧方遴荐仓促地付诸单边步调，令业界荒谬失望。

　　欧方通过IPI排斥中企出医疗采购环球采购，以及增多腹地化条款的作念法对中国研究居品以及中国供应商严重的脑怒性和排他性步调，咱们对欧方这一污蔑公谈竞争市集环境的作念法暗示执意反对，对其对中欧在医疗规模买卖及投资相关发展所带来的冲击暗示严正存眷。

　　咱们号召欧方立即罢手这一作假作念法，为在欧医疗规模中企提供公谈、平正和非脑怒性的营商环境。

　　Statement： CCCEU Opposes EU‘s Discriminatory IPI Action Against Chinese Companies

　　June 20， 2025， Brussels

　　On 20 June 2025， the European Commission announced the exclusion of Chinese companies from participating in EU public procurement of medical devices exceeding €5 million， following its investigation under the International Procurement Instrument （IPI）． It also imposed a cap， limiting the share of Chinese-origin products and components in awarded contracts to no more than 50%． The China Chamber of Commerce to the EU （CCCEU） expresses deep dissatisfaction and strongly opposes these unilateral and discriminatory measures taken by the EU．

　　The CCCEU considers the IPI findings neither impartial nor based on objective facts． The claim that most EU products and suppliers face discriminatory treatment in China’s public procurement market does not reflect reality． 

　　China and the EU have long maintained exchanges on issues related to the WTO Agreement on Government Procurement （GPA） and public procurement practices． Against this backdrop， the EU’s rushed adoption of unilateral measures is deeply disappointing to the business community．

　　The decision to exclude Chinese firms and impose localisation requirements is a blatant act of discrimination against Chinese products and suppliers in the EU’s medical public procurement sector． It seriously distorts fair competition and undermines the principle of a level playing field．

　　We urge the EU to take steps to reverse this regrettable decision and restore a fair， equitable， and non-discriminatory business environment for Chinese enterprises operating in the EU．

　END

包袱裁剪：石秀珍 SF183